Feladilimab
Feladilimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Feladilimab is under investigation in clinical trial NCT04128696 (Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma).
| Trade Name | Feladilimab |
| Generic | Feladilimab |
| Feladilimab Other Names | Feladilimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Feladilimab
